These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37770968)

  • 1. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
    Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
    J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
    Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
    J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
    Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1.
    Nguyen K; Jin Y; Howell M; Hsiao CC; Wiemer AJ; Vinogradova O
    J Immunol; 2023 Jul; 211(1):23-33. PubMed ID: 37171180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of BTN3A1 on CD14
    Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers.
    Fulford TS; Soliman C; Castle RG; Rigau M; Ruan Z; Dolezal O; Seneviratna R; Brown HG; Hanssen E; Hammet A; Li S; Redmond SJ; Chung A; Gorman MA; Parker MW; Patel O; Peat TS; Newman J; Behren A; Gherardin NA; Godfrey DI; Uldrich AP
    Nat Immunol; 2024 Aug; 25(8):1355-1366. PubMed ID: 39014161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
    Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
    Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
    Nehama D; Di Ianni N; Musio S; Du H; Patané M; Pollo B; Finocchiaro G; Park JJH; Dunn DE; Edwards DS; Damrauer JS; Hudson H; Floyd SR; Ferrone S; Savoldo B; Pellegatta S; Dotti G
    EBioMedicine; 2019 Sep; 47():33-43. PubMed ID: 31466914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTN3A1 expressed in cervical cancer cells promotes Vγ9Vδ2 T cells exhaustion through upregulating transcription factors NR4A2/3 downstream of TCR signaling.
    Liu J; Wu M; Yang Y; Mei X; Wang L; Wang J; Wang Z; He S; Liu H; Jiang H; Qu S; Zhang Y; Chen Y; Tian X; Huang Y; Wang H
    Cell Commun Signal; 2024 Sep; 22(1):459. PubMed ID: 39342337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
    Riganti C; Castella B; Massaia M
    Front Immunol; 2018; 9():1246. PubMed ID: 29937767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.
    Sakunrangsit N; Khuisangeam N; Inthanachai T; Yodsurang V; Taechawattananant P; Suppipat K; Tawinwung S
    Cancer Immunol Immunother; 2024 Apr; 73(6):98. PubMed ID: 38619641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production.
    Alice AF; Kramer G; Bambina S; Bahjat KS; Gough MJ; Crittenden MR
    Sci Rep; 2021 Aug; 11(1):16347. PubMed ID: 34381163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoantigen sensing combines TCR-dependent recognition of the BTN3A IgV domain and germline interaction with BTN2A1.
    Willcox CR; Salim M; Begley CR; Karunakaran MM; Easton EJ; von Klopotek C; Berwick KA; Herrmann T; Mohammed F; Jeeves M; Willcox BE
    Cell Rep; 2023 Apr; 42(4):112321. PubMed ID: 36995939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of the alpha
    Cobb DA; de Rossi J; Liu L; An E; Lee DW
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35210306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
    Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
    Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.